Friday, May 9, 2014
FDA Meeting is This Tuesday!
This is a rare and important opportunity for PAH patients and their loved ones to speak directly with FDA drug reviewers. The conversation will help FDA stay focused on patient needs when making decisions about the safety and effectiveness of new PH drugs.
Webcast: If you registered to participate by webcast, look for an email from FDA with log-in information.
Tuesday, May 13; 1-5 p.m. ET
10903 New Hampshire Avenue
Building 31, Great Room
Silver Spring, MD 20993
Additional information about the meeting is available as a 15-minute webinar or as a PDF. You can also contact Katie at KatherineK@PHAssociation.org or 301-565-3004 x749.